Real-World Impact

Saving Lives with Rapid,
Accurate Sepsis Detection

Real-World Impact

After six months of using IntelliSep, our results show that a higher percentage of patients are returning home to their families earlier, at lower cost for them and the hospital. Our ability to improve patient flow has been revolutionary.”

Dr. Christopher Thomas

IntelliSep: One Site’s Experience

Relative risk reduction in 30-day sepsis associated mortality rate

Reduction in blood cultures

Increase in blood cultures among high-risk Band 3 patients

Reduction in average LOS per ICU in-patient

Estimated cost savings per sepsis patient due to reduction in LOS

Reduction in Code Sepsis alerts from 30 to 6 per day

Increased speed-to-bed for Band 3 patients compared to Band 1 patients, enabled by IntelliSep and Code Sepsis protocol

Increase in SEP-1 compliance while
reducing use of resources

The above Impact Notes regarding IntelliSep were generated by the Emergency Department of an 900-Bed Regional Medical Center over a 90-day period and were based on their institutional practices and site validation of IntelliSep.
See the IntelliSep Test Instructions for Use for all cleared claims and performance data.

  1. Thomas CB, Wyler B, D’Antonio CM, Laperouse M, et al. Impact of a Sepsis Quality Improvement Initiative on Clinical and Operational Outcomes.Healthcare. 2025; 13(11):1273.
  2. AHRQ Report to Congress: An Assessment of Sepsis in the United States and its Burden on Hospital Care (2023)
  3. Assuming average $2,941 cost per inpatient day; $25,000 per sepsis admission and LOS of 8.5 days
  4. Cytovale. IntelliSep Site Experience. Case study with Our Lady of the Lake Regional Medical Center. 2023. [MKG 0148].
  5. Cytovale. From Test to Treatment: Clinical Interpretation, Rationale, and Impact of the IntelliSep Test. 2024.
  6. Thomas CB, Richard K, Grantham A, Jagneaux T, Sorrells M, O’Neal H. Investigation of the Effect of Implementing a Host Response Test on SEP-1 Compliance. Presented at: ACEP Scientific Assembly; 2025 Oct; Salt Lake City, UT.